COMMUNIQUÉS West-GlobeNewswire

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges
19/11/2025
First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs Teva's first-ever global innovation platform aims to accelerate patient impact and drive [...]
GUERBET : Financial agenda for 2026
19/11/2025
Financial agenda for 2026 Villepinte, November 19, 2025 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2026. Publications [...]
GUERBET : Calendrier financier de l’exercice 2026
19/11/2025
Calendrier financier de l’exercice 2026 Villepinte, le 19 novembre 2025 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, publie son calendrier financier [...]
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer
19/11/2025
Curium has entered a partnership with the Czech company ÚJV Řež, a leading expert in the development and production of radiopharmaceuticals, to manufacture diagnostic radiopharmaceuticals for patients with prostate [...]
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
19/11/2025
FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative [...]
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
19/11/2025
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's [...]
Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform
19/11/2025
PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in preclinical studies Provisional patent application on the novel drug delivery platform which can be [...]
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
19/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced it has repurchased and [...]
LUKE and Asset Health Forge National Partnership to Advance Human Flourishing for America’s Heroes
19/11/2025
ROCKLEDGE, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the United States Government, today announced a strategic partnership with Asset Health, a [...]
Johns Hopkins Health Plans Announces New VP of Medicare Advantage
19/11/2025
Lori Rund Brings Industry Experience, Strategic Expertise and Innovative Leadership HANOVER, Md., Nov. 19, 2025 (GLOBE NEWSWIRE) -- On Nov. 3, Lori Rund joined Johns Hopkins Health Plans as Vice President of Medicare [...]
Spryte Medical Receives FDA IDE Approval to Initiate “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment
19/11/2025
BEDFORD, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spryte Medical, a pioneer in intravascular neuro imaging, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug [...]
HealthEx appoints Jeremy Schwarz as Chief Commercial Officer
19/11/2025
SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- HealthEx , a modern data rights management platform that enables individuals to securely access and share their health records for personal use or with any trusted third [...]
Cellution Biologics Inc. Announces U.S. Launch of AmnioPlast 1 and AmnioPlast Double for Ocular Surface Repair
19/11/2025
ROSWELL, Ga., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellution Biologics Inc., today announced the introduction of AmnioPlast 1™ ( Dehydrated Monolayered Human Amnion Membrane Allograft) and AmnioPlast Double™ (Dehydrated, [...]
USOSM Partner Practices Accredited by AAAHC, Recognized as Oral and Maxillofacial Centers of Excellence
19/11/2025
IRVING, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Accreditation Association for Ambulatory Health Care ( AAAHC ) has accredited two additional U.S. Oral Surgery Management ( USOSM ) partner practices. They are North [...]
RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement
19/11/2025
Glen Rock, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases [...]
Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for Employees Residing in Japan
19/11/2025
Tokyo, Japan and Cambridge, UK, 19 November 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) announces that its Board of Directors have decided to replace the current Restricted Share Unit (“RSU”) Plan [...]
BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth
19/11/2025
November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth. Copenhagen, Denmark, November 19, 2025, (GLOBE NEWSWIRE) – BioPorto A/S [...]
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
19/11/2025
Aptose Biosciences minority shareholders to receive C$2.41 in cash per share in a “go private” transaction SAN DIEGO and TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) ( [...]
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
19/11/2025
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses 1,2 Lunsumio subcutaneous offers [...]

Pages